cloning and expression of mycobacterium tuberculosis esat-6 in prokaryotic system
Authors
abstract
the identification of a large number of antigens with potential for development of new tuberculosis vaccine has been accomplished in recent years. this study was designed for cloning and expression of esat-6 as a potent antigen of mycobacterium tuberculosis. selected gene (rv3875) was amplified by pcr and product was ligated into expressing plasmid vector pqe30 and recombinant pqe30-es plasmid was constructed. this hybrid vector was transformed in e. coli m15 and expressed in optimal condition. the expressed protein was analyzed on sds-page and confirmed by western blotting using specific antisera to esat-6. we successfully cloned and expressed esat-6 (his)6 from m. tuberculosis h37rv genome. as well as usage for serodiagnosis, this recombinant protein offers the potential development of other vaccine formats such as dna or subunit vaccines against tuberculosis.
similar resources
Cloning and Expression of Mycobacterium Tuberculosis ESAT-6 in Prokaryotic System
The identification of a large number of antigens with potential for development of new tuberculosis vaccine has been accomplished in recent years. This study was designed for cloning and expression of ESAT-6 as a potent antigen of Mycobacterium tuberculosis. Selected gene (Rv3875) was amplified by PCR and product was ligated into expressing plasmid vector pQE30 and recombinant pQE30-ES plasmi...
full textcloning, expression and purification of mycobacterium tuberculosis esat-6 and cfp-10 antigens.
background and objectives: esat-6 (6-kdaearly secretory antigenic target) and cfp-10 (10-kda culture filtrate protein) have been described as dominant antigens recognized by t-cells and considered as virulence factors in mycobacterium tuberculosis . the aim of this study was to clone, express and purify recombinant esat-6 andcfp-10 proteins of m. tuberculosis in soluble form. materials and meth...
full textCloning, expression and purification of Mycobacterium tuberculosis ESAT-6 and CFP-10 antigens
BACKGROUND AND OBJECTIVES ESAT-6 (6-kDaearly secretory antigenic target) and CFP-10 (10-kDa culture filtrate protein) have been described as dominant antigens recognized by T-cells and considered as virulence factors in Mycobacterium tuberculosis. The aim of this study was to clone, express and purify recombinant ESAT-6 andCFP-10 proteins of M. tuberculosis in soluble form. MATERIALS AND METH...
full textcloning, expression and purification of mycolyltransferase c of mycobacterium tuberculosis in prokaryotic host
objective: antigen 85 complex of mycobacterium tuberculosis includes three immunogenic proteins which are important tb vaccine candidates. the use of these protein as a component of subunit vaccines, as a part of dna vaccines or recombinant bcg boosters, enhances their recombinant production. recombinant production of these mycobacterial proteins located in the cell wall somehow differs from th...
full textESAT-6 subunit vaccination against Mycobacterium tuberculosis.
The ESAT-6 antigen from Mycobacterium tuberculosis is a dominant target for cell-mediated immunity in the early phase of tuberculosis (TB) in TB patients as well as in various animal models. The purpose of our study was to evaluate the potential of ESAT-6 in an experimental TB vaccine. We started out using dimethyl dioctadecylammonium bromide (DDA), an adjuvant which has been demonstrated to be...
full textMycobacterium tuberculosis ESAT-6 antigen immunogenicity in Owl Monkeys
Several ESAT-6-based vaccines have been widely studied in different animal models, presenting potent ability to induce both cellular and humoral responses. As ESAT-6 is a well-characterized mycobacterial antigen, its capacity to induce immune responses in a nonhuman primate model has been evaluated. The immunization of recombinant ESAT-6 (rESAT-6) in Aotus nancymaae monkeys has elicited a stron...
full textMy Resources
Save resource for easier access later
Journal title:
archives of razi institutePublisher: razi vaccine & serum research institute (rvsri)
ISSN 0365-3439
volume 64
issue 1 2016
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023